Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

General > General - Laatste dingen 2 > Flashcards

General - Laatste dingen 2 Flashcards

1
Q

Pseudomonas commensal bacterial keratitis
a. true
b. false

A

b. false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Radiation best outcome in sarcoids
a. true
b. false

A

a. true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Corneal stromal degeneration
a. MMP-1, MMP-3, serine proteases
b. MMP-1, MMP-3, choline proteases
c. MMP-2, MMP-9, serine proteases
d. MMP-2, MMP-6, choline proteases

A

c. MMP-2, MMP-9, serine proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Doxycycline –> less activity of MMP
a. true
b. false

A

a. true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Afferent PLR
a. II
b. III
c. VI

A

a. II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Efferent PLR
a. II
b. III
c. VI

A

b. III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ERU
a. TH1
b. TH2
c. TH17

A

a. TH1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Optic disk
a. tapetal
b. non-tapetal

A

b. non-tapetal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

B-blockers and carbonic anhydrase inhibitors
a. decrease aqueuos production
b. increase aqueous outflow

A

a. decrease aqueuos production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin in geriatric donkeys (like horses)
a. lower
b. same
c. higher

A

c. lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Glucose-curve donkeys
a. right shifted
b. left shifted

A

a. right shifted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leptin in older and in fat donkeys
a. lower
b. same
c. higher

A

c. higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T3/T4 in donkeys
a. lower
b. same
c. higher

A

c. higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Phenylbutazone vs. thyroid hormones
a. lower
b. same
c. higher

A

a. lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Corticosteroids vs. thyroid hormones
a. lower
b. same
c. higher

A

a. lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phenylbutazone in miniature donkeys
a. shorter half-life
b. same half-life
c. longer half-life

A

a. shorter half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Polyurethane or polypropylene
a. polyurethane
b. polypropylene

A

a. polyurethane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Maintenance fluids vs. replacement crystalloids
a. higher Ca/P/Mg
b. same Ca/P/Mg
c. lower Ca/P/Mg

A

a. higher Ca/P/Mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Replacement fluid vs. maintenance fluids
a. Higher Na/Cl
b. Same Na/Cl
c. Lower Na/Cl

A

a. Higher Na/Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Long-term fluid therapy BEss
a. high Na/K, low Mg/Ca
b. high Na, low K/Mg/Ca
c. low Na/K/Mg/Ca
d. high Na/K/Mg/Ca

A

b. high Na, low K/Mg/Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ECF and VS
a. ECF 20%, VS 5%
b. ECF 30%, VS 8%
c. ECF 35%, VS 10%
d. ECF 40%, VS 12%

A

b. ECF 30%, VS 8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

LRS vs. plasma
a. Lower Na/Cl
b. Lower Na, higher Cl
c. Higher Na/Cl
d. Higher Na, lower Cl

A

b. Lower Na, higher Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

PF abdominal surgery no enterotomy
a. WBC increase 1-4 days, normal 14 days
b. WBC increase 1-4 days, normal 28 days
c. WBC increase 4-7 days, normal 14 days
d. WBC increase 4-7 days, normal 28 days

A

c. WBC increase 4-7 days, normal 14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PF abdominal surgery with enterotomy
a. WBC increase 4-7 days, normal 14 days
b. WBC increase 4-7 days, normal 28 days
c. WBC increase 1-4 days, normal 14 days
d. WBC increase 1-4 days, normal 28 days

A

a. WBC increase 4-7 days, normal 14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
PF abdominal surgery with or without enterotomy a. Protein high for 1 week b. Protein high for 2 weeks c. Protein high for 3 weeks d. Protein high for 4 weeks
d. Protein high for 4 weeks
26
Alpha-1 a. chronotropic/inotropic b. inotropic + peripheral vasoconstriction c. vasodilation d. chronotropic/inotropic + vasodilation
b. inotropic + peripheral vasoconstriction
27
Post-synaptic alpha-2 a. chronotropic/inotropic b. inotropic + peripheral vasoconstriction c. vasodilation d. chronotropic/inotropic + vasodilation
c. vasodilation
28
B1 a. chronotropic/inotropic b. inotropic + peripheral vasoconstriction c. vasodilation d. chronotropic/inotropic + vasodilation
a. chronotropic/inotropic
29
B2 a. chronotropic/inotropic b. inotropic + peripheral vasoconstriction c. vasodilation d. chronotropic/inotropic + vasodilation
d. chronotropic/inotropic + vasodilation (ONLY SOME CHRONOTROPHY/INOTROPHY)
30
Physiologic dead space a. upper airways and respiratory passageways b. areas not equally perfused and ventilated
b. areas not equally perfused and ventilated
31
Anatomic dead space a. upper airways and respiratory passageways b. areas not equally perfused and ventilated
a. upper airways and respiratory passageways
32
Pa <100 mm Hg after therapy a. Pulmonary thromboembolism b. Left-to-right-shunting c. V/Q mismatch d. Diffusion disturbance
a. Pulmonary thromboembolism
33
Pa <100 mm Hg after therapy a. Pneumonia b. Right-to-left-shunting c. V/Q mismatch d. Diffusion disturbance
b. Right-to-left-shunting
34
DPG a. increase in undersaturation b. decrease in undersaturation c. increase in low PaO2 d. decrease in low PaO2
a. increase in undersaturation
35
Hypoxemia a. low oxygen in blood b. low oxygen in tissues
a. low oxygen in blood
36
Hypoxia a. low oxygen in blood b. low oxygen in tissues
b. low oxygen in tissues
37
Hydrophobic surfactant proteins a. SP-B and SP-C b. SP-A and SP-D
a. SP-B and SP-C
38
Hydrophilic surfactant proteins a. SP-B and SP-C b. SP-A and SP-D
b. SP-A and SP-D
39
Maxillary artery a. Medial compartment b. Lateral compartment
b. Lateral compartment
40
Biggest compartment a. Medial compartment b. Lateral compartment
a. Medial compartment
41
Mycotic plaques a. External maxillary artery b. Internal carotid artery c. External carotid artery
b. Internal carotid artery
42
Mycotic plaques a. roof medial compartment b. lateral wall lateral compartment
a. roof medial compartment
43
Internal carotid artery a. Medial compartment b. Lateral compartment
a. Medial compartment
44
External carotid artery a. Medial compartment b. Lateral compartment
b. Lateral compartment
45
Purpura hemorrhagica a. type I b. type II c. type III d. type IV
c. type III
46
AHS - peracute a. Pulmonary b. Cardiac and pulmonary c. Myocardial
a. Pulmonary
47
AHS - acute a. Pulmonary b. Cardiac and pulmonary c. Myocardial
b. Cardiac and pulmonary
48
Type I pneumocytes a. secrete surfactant proteins b. line alveolar surface
b. line alveolar surface
49
Type II pneumocytes a. secrete surfactant proteins b. line alveolar surface
a. secrete surfactant proteins
50
Type I pneumocytes a. flat and thin b. cubic
a. flat and thin
51
Type II pneumocytes a. flat and thin b. cubic
b. cubic
52
Muscle type 1 fiber a. lower glycogen and glycolytic capacity b. lower lipid and oxidative capacity
a. lower glycogen and glycolytic capacity
53
Muscle type 1 fiber a. higher glycogen and glycolytic capacity b. higher lipid and oxidative capacity
b. higher lipid and oxidative capacity
54
Dantrolene sodium a. decrease release of Ca from SR b. increase release of Ca from SR
a. decrease release of Ca from SR
55
Acute rhabdomyolysis a. low Na/Cl/K b. low Na/Cl, high K c. high Na/Cl, low K d. high Na/Cl/K
b. low Na/Cl, high K
56
PSSM-1 a. amylase resistant b. amylase sensitive
a. amylase resistant
57
PSSM-2 a. amylase resistant b. amylase sensitive
b. amylase sensitive
58
Myotonia congenita a. RYR-1 b. SCN4A c. CLCN1 d. CIAM
c. CLCN1
59
Adiponectin a. insulin-sensitizing hormone b. insulin desentisizing hormone
a. insulin-sensitizing hormone
60
Leptin in IR a. higher b. normal c. lower
a. higher
61
Glutamate a. inhibitory neurotransmitter b. excitatory neurotransmitter
b. excitatory neurotransmitter
62
Aspartate a. inhibitory neurotransmitter b. excitatory neurotransmitter
b. excitatory neurotransmitter
63
Acetylcholine a. inhibitory neurotransmitter b. excitatory neurotransmitter
b. excitatory neurotransmitter
64
GABA a. inhibitory neurotransmitter b. excitatory neurotransmitter
a. inhibitory neurotransmitter
65
Glycine a. inhibitory neurotransmitter b. excitatory neurotransmitter
a. inhibitory neurotransmitter
66
Taurine a. inhibitory neurotransmitter b. excitatory neurotransmitter
a. inhibitory neurotransmitter
67
Norepinephrine a. inhibitory neurotransmitter b. excitatory neurotransmitter
a. inhibitory neurotransmitter
68
Prehension/swallowing a. V, VII, IX, XII b. V, VII, IX, X, XII c. VII, IX, X, XI, XII d. V, VII, IX, X, XI, XII
d. V, VII, IX, X, XI, XII
69
THO a. VII, VIII b. IX, X c. VII, VIII, IX d. VII, VIII, IX, X
d. VII, VIII, IX, X
70
Slaframine a. Ranusei solifra b. Rinasi sercumsepti c. Rhinofalei surrati d. Rhizoctonia leguminicola
d. Rhizoctonia leguminicola
71
EAdV1 a. ubiquitous b. only in respiratory disease and diarrhea
a. ubiquitous
72
EAdV2 a. ubiquitous b. only in respiratory disease and diarrhea
b. only in respiratory disease and diarrhea
73
Leptin a. increases after meal b. same after meal c. decreases after meal
a. increases after meal
74
Correlation with total body fat a. Leptin / adiponectin positively correlated b. Leptin positively correlated, adiponectin negatively correlated c. Leptin negatively correlated, adiponectin positively correlated d. Leptin / adiponectin negatively correlated
b. Leptin positively correlated, adiponectin negatively correlated
75
Primary bile acids a. cholate and chenodeoxycholate b. cholate and lithocholate c. deoxycholate and lithocholate d. deoxycholate and chenodeoxychoalte
a. cholate and chenodeoxycholate
76
Secondary bile acids a. cholate and chenodeoxycholate b. cholate and lithocholate c. deoxycholate and lithocholate d. deoxycholate and chenodeoxychoalte
c. deoxycholate and lithocholate
77
Aldosterone a. Na retention b. Na and H2O retention c. Na excretion d. Na and H2O extrection
b. Na and H2O retention
78
Lipase a. excretion VLDL by liver b. excretion VLDL by adipose tissue c. uptake VLDL by adipose tissue d. lipolysis adipose tissue
c. uptake VLDL by adipose tissue
79
Hormone-sensitive lipase a. excretion VLDL by liver b. excretion VLDL by adipose tissue c. uptake VLDL by adipose tissue d. lipolysis adipose tissue
d. lipolysis adipose tissue
80
Lipemia --> creatinine a. decrease b. increase c. falsely decrease d. falsely increase
d. falsely increase
81
Reactive/secondary systemic amyloidosis a. SAA b. amyloid light-chain fibrils
a. SAA
82
Systemic primary, immunocytic, or idiopathic amyloidosis a. SAA b. amyloid light-chain fibrils
b. amyloid light-chain fibrils
83
Most common VSD a. perimembranous between aortic and tricuspid valve b. double committed between aortic and pulmonary valves c. muscular d. TOF
a. perimembranous between aortic and tricuspid valve
84
TOF a. left ventricular outflow obstruction, left ventricular hypertrophy, VSD, dexoposition aorta b. right ventricular outflow obstruction, right ventricular hypertrophy, VSD, dexoposition aorta c. left ventricular outflow obstruction, right ventricular hypertrophy, VSD, dexoposition aorta d. right ventricular outflow obstruction, left ventricular hypertrophy, VSD, dexoposition aorta
b. right ventricular outflow obstruction, right ventricular hypertrophy, VSD, dexoposition aorta
85
V200 lower a. musculoskeletal injury b. respiratory disease
a. musculoskeletal injury
86
V200 lower a. cardiovascular disease b. respiratory disease
a. cardiovascular disease
87
VLa4 lower a. cardiovascular disease b. respiratory disease c. musculoskeletal injury
b. respiratory disease
88
Class I antiarrhytmic agents a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
a. Na-channel blockers
89
Class II antiarrhytmic agents a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
d. bèta-adrenoceptor antagonist
90
Class III antiarrhytmic agents a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
c. K-channel blockers
91
Class IV antiarrhytmic agents a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
b. Ca-channel blockers
92
Quinidine a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
a. Na-channel blockers
93
Proceinamide a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
a. Na-channel blockers
94
Lidocaine a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
a. Na-channel blockers
95
Phenytoin a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
a. Na-channel blockers
96
Propanolol a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
d. bèta-adrenoceptor antagonist
97
Sotalol a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
d. bèta-adrenoceptor antagonist
98
Amiodarone a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
c. K-channel blockers (> ADVERSE EFFECTS)
99
Diltiazem a. Na-channel blockers b. Ca-channel blockers c. K-channel blockers d. bèta-adrenoceptor antagonist
b. Ca-channel blockers
100
Furosemide a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O) b. potassium-sparing diuretic
a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O)
101
Amiloride a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O) b. potassium-sparing diuretic
b. potassium-sparing diuretic
102
Thiazide a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O) b. potassium-sparing diuretic
b. potassium-sparing diureticA
103
Amiloride a. inhibit Na-selective channels in late DCT and CD b. Inhibit Na/Cl symporter in DCT c. act as aldosterone agonist d. ACE inhibitor
a. inhibit Na-selective channels in late DCT and CD
104
Thiazide a. inhibit Na-selective channels in late DCT and CD b. Inhibit Na/Cl symporter in DCT c. act as aldosterone agonist d. ACE inhibitor
b. Inhibit Na/Cl symporter in DCT
105
Mineralocorticoid inhibitor a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O) b. potassium-sparing diuretic
b. potassium-sparing diuretic
106
Mineralocorticoid inhibitor a. inhibit Na-selective channels in late DCT and CD b. Inhibit Na/Cl symporter in DCT c. act as aldosterone agonist d. ACE inhibitor
c. act as aldosterone agonist
107
Benazepril a. inhibit Na-selective channels in late DCT and CD b. Inhibit Na/Cl symporter in DCT c. act as aldosterone agonist d. ACE inhibitor
d. ACE inhibitor
108
ACE inhibitor a. blocks renin --> angiotensin I b. blocks angiotensin I --> angiotensin II c. blocks angiotensin II --> aldosterone d. bllocks angiotensin --> stimulation ADH
b. blocks angiotensin I --> angiotensin II
109
Digoxin a. cardiac glycoside b. positive inotrope c. inhibition Na/K ATPase d. all above
d. all above
110
Order a. AV node --> bundle branches --> His bundle --> Purkinje system b. AV node --> Purkinje system --> bundle branches --> His bundle c. AV node --> His bundle --> Purkinje system --> bundle branches d. AV node --> His bundle --> bundle branches --> Purkinje system
d. AV node --> His bundle --> bundle branches --> Purkinje system
111
Ta wave a. ventricular depolarization b. ventricular repolarization c. atrial depolarization d. atrial repolarization
d. atrial repolarization
112
Hyperalgesia a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue) b. increased sensitivity to nonnoxious stimuli c. exaggerated pain sensation to nociceptive stimuli d. pain produced by nonnoxious stimuli
a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue)
113
Allodynia a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue) b. increased sensitivity to nonnoxious stimuli c. exaggerated pain sensation to nociceptive stimuli d. pain produced by nonnoxious stimuli
d. pain produced by nonnoxious stimuli
113
Hyperpathie a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue) b. increased sensitivity to nonnoxious stimuli c. exaggerated pain sensation to nociceptive stimuli d. pain produced by nonnoxious stimuli
c. exaggerated pain sensation to nociceptive stimuli
114
Hyperesthesia a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue) b. increased sensitivity to nonnoxious stimuli c. exaggerated pain sensation to nociceptive stimuli d. pain produced by nonnoxious stimuli
b. increased sensitivity to nonnoxious stimuli

General (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions